Oslo, May 10: Hemispherian are a Norwegian oncology start-up looking at blocking DNA repair in tumour cells. They are initially targeting brain tumours and creating such excitement in a poorly served area that leading neurosurgeons Dr Roger Stupp from Northwestern, Dr Michael Lim from Stanford and Dr Monika Hegi from Lausanne have joined as scientific advisers www.hemispherian.com